BOLT
Price
$5.61
Change
-$0.00 (-0.00%)
Updated
Jun 27 closing price
Capitalization
10.75M
38 days until earnings call
NKTR
Price
$25.76
Change
-$3.92 (-13.21%)
Updated
Jun 27 closing price
Capitalization
319.6M
39 days until earnings call
Interact to see
Advertisement

BOLT vs NKTR

Header iconBOLT vs NKTR Comparison
Open Charts BOLT vs NKTRBanner chart's image
Bolt Biotherapeutics
Price$5.61
Change-$0.00 (-0.00%)
Volume$24.99K
Capitalization10.75M
Nektar Therapeutics
Price$25.76
Change-$3.92 (-13.21%)
Volume$4.79M
Capitalization319.6M
BOLT vs NKTR Comparison Chart in %
Loading...
BOLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NKTR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BOLT vs. NKTR commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BOLT is a Buy and NKTR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (BOLT: $5.61 vs. NKTR: $25.76)
Brand notoriety: BOLT: Not notable vs. NKTR: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BOLT: 92% vs. NKTR: 256%
Market capitalization -- BOLT: $10.75M vs. NKTR: $319.6M
BOLT [@Biotechnology] is valued at $10.75M. NKTR’s [@Biotechnology] market capitalization is $319.6M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BOLT’s FA Score shows that 1 FA rating(s) are green whileNKTR’s FA Score has 0 green FA rating(s).

  • BOLT’s FA Score: 1 green, 4 red.
  • NKTR’s FA Score: 0 green, 5 red.
According to our system of comparison, both BOLT and NKTR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BOLT’s TA Score shows that 3 TA indicator(s) are bullish while NKTR’s TA Score has 6 bullish TA indicator(s).

  • BOLT’s TA Score: 3 bullish, 3 bearish.
  • NKTR’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, NKTR is a better buy in the short-term than BOLT.

Price Growth

BOLT (@Biotechnology) experienced а -3.11% price change this week, while NKTR (@Biotechnology) price change was +202.70% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

BOLT is expected to report earnings on Aug 06, 2025.

NKTR is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NKTR($320M) has a higher market cap than BOLT($10.8M). NKTR YTD gains are higher at: 84.660 vs. BOLT (-47.580). BOLT has higher annual earnings (EBITDA): -61.54M vs. NKTR (-97.97M). NKTR has more cash in the bank: 219M vs. BOLT (38.8M). BOLT has less debt than NKTR: BOLT (24.7M) vs NKTR (100M). NKTR has higher revenues than BOLT: NKTR (87.2M) vs BOLT (3.64M).
BOLTNKTRBOLT / NKTR
Capitalization10.8M320M3%
EBITDA-61.54M-97.97M63%
Gain YTD-47.58084.660-56%
P/E RatioN/AN/A-
Revenue3.64M87.2M4%
Total Cash38.8M219M18%
Total Debt24.7M100M25%
FUNDAMENTALS RATINGS
NKTR: Fundamental Ratings
NKTR
OUTLOOK RATING
1..100
49
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
84
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BOLTNKTR
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
73%
Bearish Trend 3 days ago
88%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
76%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
75%
Advances
ODDS (%)
Bullish Trend 4 days ago
71%
Bullish Trend 4 days ago
75%
Declines
ODDS (%)
Bearish Trend 13 days ago
90%
Bearish Trend 12 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
72%
View a ticker or compare two or three
Interact to see
Advertisement
BOLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NKTR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TME19.100.40
+2.14%
Tencent Music Entertainment Group
CVLG24.290.48
+2.02%
Covenant Logistics Group Inc
CALM99.160.58
+0.59%
Cal-Maine Foods
PETZ0.97N/A
-0.02%
TDH Holdings
CMBM0.38-0.01
-2.01%
Cambium Networks Corp

BOLT and

Correlation & Price change

A.I.dvisor tells us that BOLT and ARMP have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BOLT and ARMP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BOLT
1D Price
Change %
BOLT100%
N/A
ARMP - BOLT
32%
Poorly correlated
+4.71%
NKTR - BOLT
31%
Poorly correlated
-13.21%
ELVN - BOLT
31%
Poorly correlated
-3.95%
XENE - BOLT
31%
Poorly correlated
+0.62%
LEGN - BOLT
30%
Poorly correlated
+3.43%
More

NKTR and

Correlation & Price change

A.I.dvisor indicates that over the last year, NKTR has been loosely correlated with CRNX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if NKTR jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NKTR
1D Price
Change %
NKTR100%
-13.21%
CRNX - NKTR
43%
Loosely correlated
-0.10%
XNCR - NKTR
41%
Loosely correlated
-3.10%
YMAB - NKTR
41%
Loosely correlated
-2.08%
ABCL - NKTR
40%
Loosely correlated
-3.48%
ATOS - NKTR
40%
Loosely correlated
+1.64%
More